Affected Systems |
|
|
|
|
adipose tissue
|
√
|
|
|
abnormal fat cell mitochondrial morphology
|
√
|
|
|
increased white fat cell size
|
√
|
|
|
increased gonadal fat pad weight
|
√
|
|
|
abnormal mesenteric fat pad morphology
|
√
|
|
|
abnormal brown adipose tissue thermogenesis
|
√
|
|
|
cardiovascular system
|
|
√
|
|
enlarged heart
|
|
√
|
|
cellular
|
√
|
√
|
√
|
abnormal mitochondrial morphology
|
√
|
|
√
|
abnormal fat cell mitochondrial morphology
|
√
|
|
|
decreased mitochondrial DNA content
|
√
|
|
|
abnormal mitochondrial crista morphology
|
|
√
|
√
|
abnormal mitochondrial shape
|
|
√
|
|
abnormal muscle fiber mitochondrial morphology
|
|
|
√
|
increased mitochondrial size
|
√
|
|
|
dilated mitochondrion
|
|
√
|
√
|
abnormal cell physiology
|
√
|
|
|
decreased cellular sensitivity to alkylating agents
|
√
|
|
|
decreased fatty acid beta-oxidation
|
√
|
|
|
growth/size/body
|
√
|
√
|
|
enlarged heart
|
|
√
|
|
increased body weight
|
√
|
|
|
increased susceptibility to diet-induced obesity
|
√
|
|
|
decreased body size
|
|
√
|
|
decreased body weight
|
|
√
|
|
homeostasis/metabolism
|
√
|
|
|
decreased fatty acid beta-oxidation
|
√
|
|
|
increased susceptibility to diet-induced obesity
|
√
|
|
|
abnormal blood homeostasis
|
√
|
|
|
increased circulating leptin level
|
√
|
|
|
increased circulating triglyceride level
|
√
|
|
|
increased circulating alanine transaminase level
|
√
|
|
|
increased circulating aspartate transaminase level
|
√
|
|
|
decreased body temperature
|
√
|
|
|
abnormal circadian temperature homeostasis
|
√
|
|
|
abnormal gas homeostasis
|
√
|
|
|
decreased carbon dioxide production
|
√
|
|
|
decreased oxygen consumption
|
√
|
|
|
abnormal glucose homeostasis
|
√
|
|
|
decreased circulating insulin level
|
√
|
|
|
impaired glucose tolerance
|
√
|
|
|
increased insulin sensitivity
|
√
|
|
|
decreased basal metabolism
|
√
|
|
|
immune system
|
√
|
|
|
granulomatous inflammation
|
√
|
|
|
liver/biliary system
|
√
|
|
|
hepatic steatosis
|
√
|
|
|
mortality/aging
|
|
√
|
|
neonatal lethality, incomplete penetrance
|
|
√
|
|
postnatal lethality, incomplete penetrance
|
|
√
|
|
muscle
|
|
|
√
|
abnormal muscle fiber mitochondrial morphology
|
|
|
√
|